To validate the role of the NF-κB signaling pathway in mediating the AD-induced inflammatory response in PCa, we used BAY11-7082, a NF-κB inhibitor, to determine whether suppression of NF-κB activation might inhibit IL-1β secretion (Fig. 4c). The gene discussed is NFKB1; the disease is posterior cortical atrophy.